le 11 janvier 2000 / January 11, 2000

JAMC 2000; 162(1)

© 2000 Association médicale canadienne / Canadian Medical Association

Communiqué de presse

Sujets d'intérêt

	Éditoriaux · Editorials
5	Food irradiation: Let's do it [HTML / PDF]
7	L'irradiation des aliments : Allons-y [HTML / PDF] Couverture : Les personnes qui se révèlent incapables de tracer sur une horloge la position des aiguilles indiquant 10 h 50 pourraient être atteintes de la maladie d'Alzheimer. Dans ce numéro, David Munoz et Howard Feldman passent en revue les facteurs de risque de cette maladie (page 65).

11	Correspondance · Letters [HTML / PDF] Directives aux correspondants
	Diabetes in Aboriginal populations Anticoagulant prophylaxis against stroke Reference-based pricing Furbies Treating TB Corrections

	Recherche · Research
21	HIV infection and risk behaviours among young gay and bisexual men in Vancouver S.A. Strathdee et al [full article in HTML / full article in PDF]
29	Development, dissemination, implementation and evaluation of a clinical pathway for oxygen therapy C. Wong et al [full article in HTML / full article in PDF]
37	A quantitative ranking of Canada's research output of original human studies for the decade 1989 to 1998 R.E. Gagnon et al [full article in HTML / full article in PDF]

	Exposé de recherche · Research Letter
45	Hypertension, self-perceived health status and use of primary care services M.M. Finkelstein [full article in HTML / full article in PDF]

	Commentaire · Commentary
47	Stroke thrombolysis: Is tissue plasminogen activator a defibrillator for the brain? A.M. Buchan, T.E. Feasby [full article in HTML / full article in PDF]
51	Beyond polemic K. Rockwood [full article in HTML / full article in PDF]
52	HIV: the millennium bug B.C. Willoughby [full article in HTML / full article in PDF]

	Synthèse ·Review
57	Tuberculosis: 12. Global disease and the role of international collaboration D.A. Enarson [full article in HTML / full article in PDF]
65	Causes of Alzheimer's disease D.G. Munoz, H. Feldman [full article in HTML / full article in PDF]
77	Erythema ab igne: an old condition new again S. Tan, V. Bertucci [full article in HTML / full article in PDF]
79	Managing neuropsychiatric disease with transcranial magnetic stimulation G. Hasey et al [full article in HTML / full article in PDF]
83	Reason for hope: the advent of disease-modifying therapies in multiple sclerosis P.W. O'Connor [full article in HTML / full article in PDF]
85	Inhaled nitric oxide for hypoxemic respiratory failure: Passing bad gas? N.D. Ferguson, J.T. Granton [full article in HTML / full article in PDF]

87	De l'Oreille Gauche · The Left Atrium [HTML / PDF]
	Beyond theory (book review by C. Ells) Fable of a beekeeper by A. Lupin Colombia's humanitarian crisis

91	Nouvelles et analyses · News and analysis [HTML / PDF]
	Poor penmanhip costs MD $225 000 It's a seller's market for Quebec's residents Auditor general slams feds' response to Salmonella outbreak NEJM editor reflects on his firing Open med-school doors wider: report Australia eyeing Canada's rural MDs Banting featured on millennium stamp Detecting hep C for $1.5 million a case On the Net: Outfitting a medical office online Canadians attract $17 million in xenotransplant funding Pulse: Caring for sick a strain on families Pediatric hospitals scrambling in wake of nursing shortage Research Update: A shot in the arm for shock to the heart An ACE inhibitor in the hole for cardiovascular prevention Thalidomide is back Cold hands? Warm gel Mad cow disease factory in lymph nodes
101	MD $200 000 richer after damning court judgement P. Sullivan [full article in HTML / full article in PDF]
102	What? A leading scientist immigrating to Canada? C. Gray [full article in HTML / full article in PDF]

175	Nécrologie · Deaths

	Gens de cœur · Heart and Soul
176	Fighting for fairness for the strangers at the gate A. Silversides [full article in HTML / full article in PDF]

Santé Canada · Health Canada Dans le Bulletin canadien sur les effets indésirables des médicaments :    [PDF] Cisapride (PrepulsidMD) : interactions Pémoline (CylertMD) : retrait du marché Bupropion (ZybanMD) : mise à jour Communiqué Médicaments d'intérêt courant (Liens vers le site web de Santé Canada)